UTI Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1339 Cr | ₹1126 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 28 Dec 2015 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare |
| Turn Over | 26.49% | 28% |
| Expense Ratio | 2.14 | 2.22 |
| Manager | Meeta Shetty | Kamal Gada |
| ISIN Code | INF277K016A9 | INF789F01695 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | -2.42% | -1.99% |
| 6 Month | 1.38% | 0.48% |
| 1 Year | -2.49% | -2.09% |
| 3 Year | 21.65% | 23.72% |
| 5 Year | 14.94% | 14.88% |
SIP Return Analysis
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | -1.22% | -1.84% |
| 1 Year | 4.63% | 5.72% |
| 3 Year | 17.22% | 19.68% |
| 5 Year | 16.69% | 17.73% |
Rolling Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 8.33% | 11.64% |
| 3 Year | 18.87% | 16.55% |
| 5 Year | 15.74% | 14.82% |
Risk Management
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 16.04% | 14.3% |
| Sharp | 0.91% | 1.08% |
| Beta | 0.98% | 0.89% |
| Alpha | -1.01% | 3.32% |
Fund Managers
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Meeta Shetty | Kamal Gada |
| Total AUM | ₹17847 Cr | ₹870 Cr |
| Funds Managed | 5 | 1 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 6.27 | 5.77 |
| Mid Cap | 39.01 | 34.95 |
| Small Cap | 35.21 | 38.55 |
| Large Cap | 19.5 | 20.74 |
Sector Allocation
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 5.02 | 1.25 |
| Healthcare | 90.83 | 97.71 |
| Basic Materials | 4.14 | 1.03 |
Top Comparisons
ICICI Prudential Technology Fund - Growth
3Y Returns15.88%
Aditya Birla Sun Life Digital India Fund - Growth - Regular Plan
3Y Returns15.05%
BANDHAN Low Duration Fund - Regular Plan - Growth
3Y Returns7.13%
Aditya Birla Sun Life Low Duration Fund - Growth Plan
3Y Returns6.92%
BANDHAN Infrastructure Fund - Regular Plan - Growth
3Y Returns22.96%
SBI Infrastructure Fund - Regular Plan - Growth
3Y Returns20.12%
HSBC Multi Asset Active FOF - Growth
3Y Returns15.55%
Mirae Asset Diversified Equity Allocator Passive FOF - Regular Growth
3Y Returns15.16%